Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare LlcfiledCriticalBayer Healthcare Llc
Priority to HN2002000068ApriorityCriticalpatent/HN2002000068A/en
Publication of HN2002000068ApublicationCriticalpatent/HN2002000068A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS Y DERIVADOS DE LOS MISMOS, SU SINTESIS Y USO COMO INHIBIDORES DE LA RHO - QUINASA, ESTOS COMPUESTOS DE LA PRESENTE INVENCION SON UTILES PARA INHIBIR EL CRECIMIENTO TUMORAL, TRATAR LA DISFUNSIÓN ERÉCTIL Y TRATAR OTRAS INDICACIONES MEDIADAS POR LA RHO - QUINASA, POR EJEMPLO LA ENFERMEDAD CARDIACA CORONARIA.THE PRESENT INVENTION REFERS TO COMPOUNDS AND DERIVATIVES THEREOF, THEIR SYNTHESIS AND USE AS INHIBITORS OF RHOD-KINASE, THESE COMPOUNDS OF THE PRESENT INVENTION ARE USEFUL TO INHIBIT TUMOR GROWTH, TREAT MEDICAL OR INDICATED DYSFUNSITION OR TREATMENTS. RH - KINASE, FOR EXAMPLE CORONARY HEART DISEASE.
HN2002000068A2002-03-222002-03-22
INHIBITORS OF THE RHO - QUINASA.
HN2002000068A
(en)
Compounds derived from 2,3-dihydro-5h- [1,3] thiazolo [3,2-a] pyrimidin-5-one, modulators of pi3k; pharmaceutical composition; and use to treat an immune-based disease, cancer, or lung disease in a patient.